AUG 22, 2019 7:46 PM PDT

Antibiotic use associated with bowel cancer

From 2000–2010, global consumption of antibiotics rose by 35% up to 70 billion doses each year. Although doctors are more cautious to prescribe antibiotics now due to the fear of antibiotic resistance, if you do the math behind those numbers, it comes down to 10 doses per person per year for the entire planet. That’s a lot.

Which begs the question – what long-term consequences might antibiotics have on our health?

New research published in the journal Gut examines just that. The authors of the study write: "Our aim was to investigate the associations between antibiotic use and site-specific colorectal cancer risk in the world's largest primary care database."

The database they refer to is the Clinical Practice Research Datalink, which holds the medical records of 11.3 million people from 674 doctor's offices in the United Kingdom. The researchers looked at data from 1989–2012 from 19,726 people who developed colon cancer and 9,254 who developed rectal cancer. They also used data from 137,077 people who did not develop bowel cancer during that time period.

They then sorted the data, categorizing the antibiotics by drug class and the type of bacteria they target, and classifying the cancers by their positions (i.e. rectum, proximal colon and distal colon).

What they found was some mixed results: a clear association between antibiotic use but in distinct ways for colon versus rectal cancer. They saw an increase in colon cancer risk associated with antibiotic use, but a decrease in rectal cancer risk.

New research links antibiotic use to bowel cancer. Photo: Pixabay

They also determined a statistically significant increase in colon cancer risk, most notably in the proximal colon, for antibiotics that target anaerobic bacteria rather than aerobic bacteria, reports Medical News Today.

Why that could be is still unclear. However, as the authors explain, "whether antibiotic exposure is causal or contributory to colon cancer risk, our results highlight the importance of judicious antibiotic use by clinicians."

Sources: Medical News Today, Gut

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 30, 2020
Cancer
Chemokines Could be the Key in Controlling Glioma Stem Cells
SEP 30, 2020
Chemokines Could be the Key in Controlling Glioma Stem Cells
The transformation of a healthy cell into a cancerous one often comes with a slew of cellular signaling changes.  T ...
OCT 07, 2020
Cancer
Beyond the eye: improving melanoma detection
OCT 07, 2020
Beyond the eye: improving melanoma detection
Research from UC San Francisco reports that it is possible to use genomic methods to detect skin damage from the sun not ...
OCT 12, 2020
Drug Discovery & Development
Researchers Solve Key Problem for Cancer Immunotherapy
OCT 12, 2020
Researchers Solve Key Problem for Cancer Immunotherapy
Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promi ...
OCT 14, 2020
Cancer
Research suggests statins could reduce the risk of cancer
OCT 14, 2020
Research suggests statins could reduce the risk of cancer
New research published in the journal eLife provides evidence that statins, the common cholesterol-lowering drugs, could ...
OCT 26, 2020
Cancer
Investigating the Receptor Protein FPR1 in Brain Cancer
OCT 26, 2020
Investigating the Receptor Protein FPR1 in Brain Cancer
Amongst the more common targets for cancer therapies are cell surface receptors. These receptors are proteins – us ...
NOV 18, 2020
Genetics & Genomics
Choosing an NGS workflow: What are you looking for?
NOV 18, 2020
Choosing an NGS workflow: What are you looking for?
  It’s easy to be overwhelmed by the number of workflows that are available for NGS. How do you choose? While ...
Loading Comments...